Login / Signup
Mark Bazett
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 2
Top Topics
Dna Damage Response
Tyrosine Kinase
Inflammatory Response
Intensive Care Unit
Top Venues
Molecular cancer research : MCR
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Daryl Griffin
,
Robbie Carson
,
Deborah Y Moss
,
Tamas Sessler
,
Deborah P Lavin
,
Vijay K Tiwari
,
Shivaali Karelia
,
Richard D Kennedy
,
Kienan I Savage
,
Simon S McDade
,
Adam Carie
,
Jim Pankovich
,
Mark Bazett
,
Sandra Van Schaeybroeck
Ruthenium drug BOLD-100 regulates BRAFMT colorectal cancer cell apoptosis through AhR/ROS/ATR signaling axis modulation.
Molecular cancer research : MCR
(2024)
Daryl Griffin
,
Robbie Carson
,
Deborah Y Moss
,
Tamas Sessler
,
Deborah P Lavin
,
Vijay K Tiwari
,
Shivaali Karelia
,
Richard D Kennedy
,
Kienan I Savage
,
Simon S McDade
,
Adam Carie
,
Jim Pankovich
,
Mark Bazett
,
Sandra Van Schaeybroeck
Ruthenium drug BOLD-100 regulates BRAFMT colorectal cancer cell apoptosis through AhR/ROS/ATR signaling axis modulation.
Molecular cancer research : MCR
(2024)